These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11113983)

  • 1. A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.
    Grace JB; Walker MP; McKeith IG
    Int J Geriatr Psychiatry; 2000 Nov; 15(11):1028-33. PubMed ID: 11113983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors for dementia with Lewy bodies.
    Wild R; Pettit T; Burns A
    Cochrane Database Syst Rev; 2003; 2003(3):CD003672. PubMed ID: 12917981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    Am J Alzheimers Dis Other Demen; 2007; 22(1):42-7. PubMed ID: 17534001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Frequency and Complexity of Sleep Disturbances in Dementia with Lewy Bodies as Compared to Alzheimer's Disease.
    Chwiszczuk L; Breitve M; Hynninen M; Gjerstad MD; Aarsland D; Rongve A
    Neurodegener Dis; 2016; 16(3-4):152-60. PubMed ID: 26551998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
    Kaufer DI
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
    Maclean LE; Collins CC; Byrne EJ
    Int Psychogeriatr; 2001 Sep; 13(3):277-88. PubMed ID: 11768375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.
    McKeith IG; Grace JB; Walker Z; Byrne EJ; Wilkinson D; Stevens T; Perry EK
    Int J Geriatr Psychiatry; 2000 May; 15(5):387-92. PubMed ID: 10822236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
    Grace J; Daniel S; Stevens T; Shankar KK; Walker Z; Byrne EJ; Butler S; Wilkinson D; Woolford J; Waite J; McKeith IG
    Int Psychogeriatr; 2001 Jun; 13(2):199-205. PubMed ID: 11495394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
    Finkel SI
    Clin Ther; 2004 Jul; 26(7):980-90. PubMed ID: 15336465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.
    Cagnin A; Fragiacomo F; Camporese G; Turco M; Bussè C; Ermani M; Montagnese S
    J Alzheimers Dis; 2017; 55(4):1529-1536. PubMed ID: 27886007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of monitoring sleep talking for the diagnosis of Dementia with Lewy bodies.
    Honda K; Hashimoto M; Yatabe Y; Kaneda K; Yuki S; Ogawa Y; Matsuzaki S; Tsuyuguchi A; Tanaka H; Kashiwagi H; Hasegawa N; Ishikawa T; Ikeda M
    Int Psychogeriatr; 2013 May; 25(5):851-8. PubMed ID: 23425512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
    Touchon J; Bergman H; Bullock R; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with lewy bodies: findings from an international multicentre study.
    Del Ser T; McKeith I; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
    Int J Geriatr Psychiatry; 2000 Nov; 15(11):1034-45. PubMed ID: 11113984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer's disease using the Multiple Sleep Latency Test.
    Ferman TJ; Smith GE; Dickson DW; Graff-Radford NR; Lin SC; Wszolek Z; Van Gerpen JA; Uitti R; Knopman DS; Petersen RC; Parisi JE; Silber MH; Boeve BF
    Alzheimers Res Ther; 2014; 6(9):76. PubMed ID: 25512763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The possible value of diagnosing MCI-DLB and treatment options].
    Feitsma MT; van Laar T; Dautzenberg PL
    Tijdschr Gerontol Geriatr; 2009 Sep; 40(4):168-72. PubMed ID: 20088343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
    McKeith I; Del Ser T; Spano P; Emre M; Wesnes K; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
    Lancet; 2000 Dec; 356(9247):2031-6. PubMed ID: 11145488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high frequency of periodic limb movements in patients with Lewy body dementia.
    Hibi S; Yamaguchi Y; Umeda-Kameyama Y; Yamamoto H; Iijima K; Momose T; Akishita M; Ouchi Y
    J Psychiatr Res; 2012 Dec; 46(12):1590-4. PubMed ID: 22835911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Mol JA
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Moerkens RM; Dhondt AD
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.